Pharma-Bio Serv, Inc. (PBSV)
USD 0.38
(-21.86%)
USD 0.38
(-21.86%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 3.94 Million USD | 6.54% |
| 2022 | 3.7 Million USD | -59.77% |
| 2021 | 9.21 Million USD | 107.46% |
| 2020 | 4.44 Million USD | -0.87% |
| 2019 | 4.47 Million USD | -2.58% |
| 2018 | 4.59 Million USD | -8.69% |
| 2017 | 5.03 Million USD | -14.28% |
| 2016 | 5.87 Million USD | 3.01% |
| 2015 | 5.7 Million USD | -6.65% |
| 2014 | 6.1 Million USD | 6.03% |
| 2013 | 5.76 Million USD | 39.24% |
| 2012 | 4.13 Million USD | 21.39% |
| 2011 | 3.4 Million USD | 22.5% |
| 2010 | 2.78 Million USD | -4.8% |
| 2009 | 2.92 Million USD | -6.78% |
| 2008 | 3.13 Million USD | -1.26% |
| 2007 | 3.17 Million USD | 42.7% |
| 2006 | 2.22 Million USD | 5464.29% |
| 2005 | 40 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 931.85 Thousand USD | -4.32% |
| 2024 Q3 | 1.01 Million USD | 9.16% |
| 2024 Q1 | 973.9 Thousand USD | -0.78% |
| 2023 Q1 | 911.52 Thousand USD | -3.0% |
| 2023 Q4 | 981.57 Thousand USD | -9.91% |
| 2023 Q3 | 1.08 Million USD | 12.75% |
| 2023 FY | 3.94 Million USD | 6.54% |
| 2023 Q2 | 966.36 Thousand USD | 6.02% |
| 2022 FY | 3.7 Million USD | -59.77% |
| 2022 Q3 | 942.8 Thousand USD | 0.81% |
| 2022 Q2 | 935.27 Thousand USD | 5.24% |
| 2022 Q1 | 888.73 Thousand USD | -85.89% |
| 2022 Q4 | 939.68 Thousand USD | -0.33% |
| 2021 Q2 | 1.02 Million USD | 3.02% |
| 2021 FY | 9.21 Million USD | 107.46% |
| 2021 Q1 | 995.98 Thousand USD | -17.41% |
| 2021 Q3 | 894.57 Thousand USD | -12.82% |
| 2021 Q4 | 6.29 Million USD | 603.91% |
| 2020 Q4 | 1.2 Million USD | 16.24% |
| 2020 Q1 | 1.04 Million USD | -5.63% |
| 2020 FY | 4.44 Million USD | -0.87% |
| 2020 Q2 | 1.14 Million USD | 9.47% |
| 2020 Q3 | 1.03 Million USD | -9.66% |
| 2019 FY | 4.47 Million USD | -2.58% |
| 2019 Q4 | 1.11 Million USD | -7.76% |
| 2019 Q1 | 1.04 Million USD | -8.05% |
| 2019 Q2 | 1.11 Million USD | 6.68% |
| 2019 Q3 | 1.2 Million USD | 7.95% |
| 2018 Q4 | 1.13 Million USD | -8.2% |
| 2018 Q3 | 1.23 Million USD | 7.23% |
| 2018 Q2 | 1.15 Million USD | 8.68% |
| 2018 Q1 | 1.06 Million USD | -5.99% |
| 2018 FY | 4.59 Million USD | -8.69% |
| 2017 Q4 | 1.13 Million USD | 0.84% |
| 2017 Q3 | 1.12 Million USD | -17.82% |
| 2017 Q2 | 1.36 Million USD | -3.57% |
| 2017 Q1 | 1.41 Million USD | -7.1% |
| 2017 FY | 5.03 Million USD | -14.28% |
| 2016 Q3 | 1.54 Million USD | 8.2% |
| 2016 Q4 | 1.52 Million USD | -1.43% |
| 2016 Q1 | 1.37 Million USD | -7.23% |
| 2016 Q2 | 1.42 Million USD | 4.02% |
| 2016 FY | 5.87 Million USD | 3.01% |
| 2015 Q1 | 1.37 Million USD | -2.62% |
| 2015 FY | 5.7 Million USD | -6.65% |
| 2015 Q4 | 1.48 Million USD | -4.49% |
| 2015 Q3 | 1.55 Million USD | 19.85% |
| 2015 Q2 | 1.29 Million USD | -6.02% |
| 2014 Q3 | 1.47 Million USD | -11.41% |
| 2014 Q4 | 1.41 Million USD | -4.47% |
| 2014 Q1 | 1.54 Million USD | -7.22% |
| 2014 FY | 6.1 Million USD | 6.03% |
| 2014 Q2 | 1.67 Million USD | 8.16% |
| 2013 Q4 | 1.66 Million USD | 15.08% |
| 2013 FY | 5.76 Million USD | 39.24% |
| 2013 Q3 | 1.44 Million USD | 5.29% |
| 2013 Q2 | 1.37 Million USD | 7.63% |
| 2013 Q1 | 1.27 Million USD | 1.55% |
| 2012 FY | 4.13 Million USD | 21.39% |
| 2012 Q4 | 1.25 Million USD | 22.49% |
| 2012 Q3 | 1.02 Million USD | 5.75% |
| 2012 Q2 | 970.33 Thousand USD | 9.68% |
| 2012 Q1 | 884.7 Thousand USD | -20.32% |
| 2011 Q3 | 831.92 Thousand USD | 2.93% |
| 2011 Q4 | 1.11 Million USD | 33.46% |
| 2011 FY | 3.4 Million USD | 22.5% |
| 2011 Q1 | 658.48 Thousand USD | -8.4% |
| 2011 Q2 | 808.24 Thousand USD | 22.74% |
| 2010 FY | 2.78 Million USD | -4.8% |
| 2010 Q2 | 678.42 Thousand USD | -3.34% |
| 2010 Q4 | 718.88 Thousand USD | 5.14% |
| 2010 Q3 | 683.74 Thousand USD | 0.78% |
| 2010 Q1 | 701.86 Thousand USD | -1.78% |
| 2009 Q2 | 789.73 Thousand USD | 10.93% |
| 2009 Q3 | 710.05 Thousand USD | -10.09% |
| 2009 Q4 | 714.59 Thousand USD | 0.64% |
| 2009 FY | 2.92 Million USD | -6.78% |
| 2009 Q1 | 711.91 Thousand USD | -14.42% |
| 2008 Q4 | 831.85 Thousand USD | 3.7% |
| 2008 Q2 | 686.01 Thousand USD | -15.92% |
| 2008 Q1 | 815.91 Thousand USD | -2.26% |
| 2008 FY | 3.13 Million USD | -1.26% |
| 2008 Q3 | 802.19 Thousand USD | 16.94% |
| 2007 FY | 3.17 Million USD | 42.7% |
| 2007 Q4 | 834.81 Thousand USD | 7.71% |
| 2007 Q3 | 775.06 Thousand USD | -6.58% |
| 2007 Q2 | 829.67 Thousand USD | 12.64% |
| 2007 Q1 | 736.58 Thousand USD | 25.93% |
| 2006 Q3 | 621.57 Thousand USD | -10.95% |
| 2006 Q4 | 584.91 Thousand USD | -5.9% |
| 2006 Q2 | 697.97 Thousand USD | 7.3% |
| 2006 FY | 2.22 Million USD | 5464.29% |
| 2006 Q1 | 650.52 Thousand USD | 0.0% |
| 2005 FY | 40 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Achiko AG | 6.78 Million USD | 41.799% |
| Accelera Innovations, Inc | - USD | -Infinity% |
| Aspyra Inc. | 8.04 Million USD | 50.9% |
| Cannabis Sativa, Inc. | 862.24 Thousand USD | -357.992% |
| CompuMed, Inc. | 2.91 Million USD | -35.361% |
| CompuGroup Medical SE & Co. KGaA | 1 Billion USD | 99.607% |
| Cogstate Limited | 23.64 Million USD | 83.296% |
| CareView Communications, Inc. | 7.21 Million USD | 45.299% |
| Craneware plc | 141.35 Million USD | 97.206% |
| Caduceus Software Systems Corp. | 2.07 Million USD | -89.917% |
| Certive Solutions Inc. | 1.5 Million USD | -161.764% |
| Drug Free Solution, Inc. | 1.39 Million USD | -182.934% |
| DATATRAK International, Inc. | 3.26 Million USD | -20.819% |
| Strainsforpains, Inc. | 149.72 Thousand USD | -2537.537% |
| Healixa Inc. | 6.56 Million USD | 39.841% |
| Easy Technologies Inc. | - USD | -Infinity% |
| eWellness Healthcare Corporation | - USD | -Infinity% |
| Founders Bay Holdings | 3.28 Million USD | -20.365% |
| Health Discovery Corporation | - USD | -Infinity% |
| Healthcare Integrated Technologies, Inc. | 702.92 Thousand USD | -461.797% |
| H-Source Holdings Ltd. | - USD | -Infinity% |
| InterCare DX, Inc. | 491.28 USD | -803718.596% |
| IQ-AI Limited | 1.13 Million USD | -249.069% |
| Cannabiz Mobile, Inc. | 750.00 USD | -526433.333% |
| Mednow Inc. | 2.78 Million USD | -41.878% |
| Galileo Life Sciences, Inc. | 270.72 Thousand USD | -1358.687% |
| MediXall Group, Inc. | 59.26 Thousand USD | -6562.955% |
| Mitesco, Inc. | 2.58 Million USD | -52.667% |
| MobileSmith, Inc. | 8.63 Million USD | 54.287% |
| NantHealth, Inc. | 94.47 Million USD | 95.82% |
| Net Medical Xpress Solutions, Inc. | 1.76 Million USD | -124.248% |
| OneLife Technologies Corp. | - USD | -Infinity% |
| ORHub, Inc. | 12.38 Million USD | 68.108% |
| Patient Access Solutions, Inc. | 9.19 Million USD | 57.045% |
| PPJ Healthcare Enterprises, Inc. | 141.33 Thousand USD | -2694.012% |
| Medical Cannabis Payment Solutions, Inc. | 12.18 Thousand USD | -32311.359% |
| Renalytix Plc | 29.04 Million USD | 86.402% |
| Revium Recovery Inc. | 677 Thousand USD | -483.309% |
| RYAH Group, Inc. | - USD | -Infinity% |
| Carepay Inc. | 369.00 USD | -1070089.702% |
| Vaso Corporation | 46.39 Million USD | 91.489% |
| Vynleads, Inc. | 200.15 Thousand USD | -1872.961% |